Your browser doesn't support javascript.
loading
Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.
Ari, Csilla; Poff, Angela M; Held, Heather E; Landon, Carol S; Goldhagen, Craig R; Mavromates, Nicholas; D'Agostino, Dominic P.
Afiliación
  • Ari C; Department of Molecular Pharmacology and Physiology, Hyperbaric Biomedical Research Laboratory, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
  • Poff AM; Department of Molecular Pharmacology and Physiology, Hyperbaric Biomedical Research Laboratory, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
  • Held HE; Department of Molecular Pharmacology and Physiology, Hyperbaric Biomedical Research Laboratory, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
  • Landon CS; Department of Molecular Pharmacology and Physiology, Hyperbaric Biomedical Research Laboratory, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
  • Goldhagen CR; Department of Molecular Pharmacology and Physiology, Hyperbaric Biomedical Research Laboratory, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
  • Mavromates N; Department of Molecular Pharmacology and Physiology, Hyperbaric Biomedical Research Laboratory, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
  • D'Agostino DP; Department of Molecular Pharmacology and Physiology, Hyperbaric Biomedical Research Laboratory, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.
PLoS One ; 9(7): e103526, 2014.
Article en En | MEDLINE | ID: mdl-25061944
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arginina / Caprilatos / Ubiquinona / Ácido gamma-Aminobutírico / Esclerosis Amiotrófica Lateral / Ácidos Cetoglutáricos Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: PLoS One Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arginina / Caprilatos / Ubiquinona / Ácido gamma-Aminobutírico / Esclerosis Amiotrófica Lateral / Ácidos Cetoglutáricos Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: PLoS One Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos